Mason Street Advisors’s HI-TECH PHARMACAL INC HITK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-1,347
Closed -$58K 1944
2014
Q1
$58K Sell
1,347
-407
-23% -$17.6K ﹤0.01% 1773
2013
Q4
$76K Buy
1,754
+132
+8% +$5.71K ﹤0.01% 1766
2013
Q3
$70K Buy
1,622
+61
+4% +$2.33K ﹤0.01% 1632
2013
Q2
$52K Buy
+1,561
New +$52K ﹤0.01% 1606

Mason Street Advisors's HITK Position: Q2 2014 in Review

Mason Street Advisors sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 1,347 shares — an estimated $58K sold.

Mason Street Advisors first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $76K in Q4 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

  • Mason Street Advisors reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
  • Mason Street Advisors sold 1,347 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $58K.
  • Mason Street Advisors first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
  • Mason Street Advisors's HI-TECH PHARMACAL INC position peaked at $76K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Mason Street Advisors's 13F filing for Q2 2014, filed 5 Aug 2014.